Paloma Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,680
| Closed | -$222K | – | 190 |
|
|
2024
Q4 | $222K | Sell |
1,680
-1,070
| -39% | -$150K | 0.01% | 236 |
|
|
2024
Q3 | $400K | Sell |
2,750
-34,218
| -93% | -$4.95M | 0.01% | 697 |
|
|
2024
Q2 | $5.07M | Buy |
36,968
+23,757
| +180% | +$3.17M | 0.14% | 120 |
|
|
2024
Q1 | $1.81M | Sell |
13,211
-43,747
| -77% | -$5.97M | 0.1% | 245 |
|
|
2023
Q4 | $7.74M | Buy |
+56,958
| New | +$6.95M | 0.28% | 55 |
|
|
2022
Q4 | – | Sell |
-23,106
| Closed | -$2.99M | – | 1028 |
|
|
2022
Q3 | $2.7M | Buy |
23,106
+20,052
| +657% | +$2.49M | 0.12% | 142 |
|
|
2022
Q2 | $359K | Buy |
+3,054
| New | +$363K | 0.01% | 719 |
|
|
2022
Q1 | – | Sell |
-21,856
| Closed | -$2.85M | – | 1983 |
|
|
2021
Q4 | $3.34M | Buy |
+21,856
| New | +$3.38M | 0.05% | 305 |
|
|
2021
Q1 | – | Sell |
-32,428
| Closed | -$5.15M | – | 2172 |
|
|
2020
Q4 | $4.91M | Buy |
32,428
+13,453
| +71% | +$1.92M | 0.13% | 164 |
|
|
2020
Q3 | $2.57M | Sell |
18,975
-264,192
| -93% | -$35.8M | 0.07% | 315 |
|
|
2020
Q2 | $38.7M | Buy |
+283,167
| New | +$36.1M | 0.67% | 12 |
|
|
2020
Q1 | – | Sell |
-322,420
| Closed | -$38.9M | – | 1612 |
|
|
2019
Q4 | $38.9M | Buy |
322,420
+68,831
| +27% | +$7.68M | 0.58% | 17 |
|
|
2019
Q3 | $25.2M | Buy |
253,589
+239,956
| +1,760% | +$25.1M | 0.52% | 28 |
|
|
2019
Q2 | $1.49M | Sell |
13,633
-153,689
| -92% | -$16.3M | 0.03% | 534 |
|
|
2019
Q1 | $18.7M | Sell |
167,322
-19,566
| -10% | -$2.15M | 0.45% | 31 |
|
|
2018
Q4 | $18M | Buy |
+186,888
| New | +$19.8M | 0.55% | 33 |
|
|
2018
Q3 | – | Sell |
-323,373
| Closed | -$38.1M | – | 1712 |
|
|
2018
Q2 | $35.5M | Buy |
323,373
+304,824
| +1,643% | +$32.6M | 0.65% | 13 |
|
|
2018
Q1 | $1.98M | Sell |
18,549
-193,579
| -91% | -$21.5M | 0.03% | 579 |
|
|
2017
Q4 | $22.6M | Buy |
212,128
+116,092
| +121% | +$12.4M | 0.3% | 36 |
|
|
2017
Q3 | $10.7M | Sell |
96,036
-384,009
| -80% | -$41M | 0.15% | 101 |
|
|
2017
Q2 | $49.6M | Buy |
480,045
+387,192
| +417% | +$38.1M | 0.59% | 14 |
|
|
2017
Q1 | $9.08M | Sell |
92,853
-56,103
| -38% | -$5.37M | 0.11% | 141 |
|
|
2016
Q4 | $13.2M | Buy |
148,956
+75,966
| +104% | +$6.91M | 0.13% | 87 |
|
|
2016
Q3 | $7.04M | Buy |
72,990
+34,782
| +91% | +$3.31M | 0.09% | 133 |
|
|
2016
Q2 | $3.28M | Buy |
+38,208
| New | +$3.43M | 0.04% | 422 |
|
|
2016
Q1 | – | Sell |
-103,149
| Closed | -$11.6M | – | 1943 |
|
|
2015
Q4 | $11.6M | Buy |
103,149
+95,244
| +1,205% | +$10.3M | 0.31% | 48 |
|
|
2015
Q3 | $799K | Sell |
7,905
-3,459
| -30% | -$415K | 0.02% | 772 |
|
|
2015
Q2 | $1.4M | Buy |
11,364
+3,081
| +37% | +$369K | 0.03% | 590 |
|
|
2015
Q1 | $948K | Sell |
8,283
-164,217
| -95% | -$18.1M | 0.03% | 513 |
|
|
2014
Q4 | $17.4M | Buy |
+172,500
| New | +$16.8M | 0.75% | 19 |
|
|
2014
Q2 | – | Sell |
-351,981
| Closed | -$27.7M | – | 1152 |
|
|
2014
Q1 | $27.7M | Buy |
+351,981
| New | +$29.3M | 1.79% | 3 |
|
Other funds holding IBB
MMEA
Paloma Partners's IBB Position: Q1 2025 in Review
Paloma Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 1,680 shares — an estimated $222K sold.
Paloma Partners first reported a position in IBB in Q1 2014 and held it in 31 quarters. The position peaked at $49.6M in Q2 2017. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.
- Paloma Partners reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
- Paloma Partners sold 1,680 iShares Biotechnology ETF shares in Q1 2025, an estimated $222K.
- Paloma Partners first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 31 quarters.
- Paloma Partners's iShares Biotechnology ETF position peaked at $49.6M in Q2 2017.
- 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.
Based on Paloma Partners's 13F filing for Q1 2025, filed 15 May 2025.